Atlas Trials

Immunological Functionnal Test Validation to Predict Melanoma Metastatic Patient Response to Checkpoint Inhibitors

Clinical trial NCT05649683 · RECRUITING

Trial details

NCT number
NCT05649683
Sponsor
Centre Hospitalier Universitaire de Nice
Status
RECRUITING
Phase
Not Applicable
Study type
INTERVENTIONAL
Melanoma (Skin)
Start date
2023-01-31
Primary completion
2027-02-01
Enrollment
60

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.